About Us
Wayfinder’s team of seasoned experts in RNA biophysics, molecular biology and machine learning is dedicated to pioneering RNA-targeting small molecule therapies.
Our advisors bring invaluable insight into biotech commercialization, medicinal chemistry and taking small molecules to the clinic.
Our Mission: Discovering treatments for currently incurable diseases
Team
-
Jason Fontana, PhD
Founder & CEO
-
David Sparkman-Yager, PhD
Founder & CTO
-
Chuhern Hwang, PhD
Founder & Head of Drug Discovery
-
Michelle Kriner, PhD
Head of Program Development
-
Rao Talasila
Head of Machine Learning
-
Nick Terrett, PhD
Medicinal Chemistry Advisor
-
Brett Israels, PhD
Senior Scientist
-
Fusayo Koyanagi
Associate Scientist
-
Nermeeta Dhillon
Applied ML Scientist
-
Wanling Kratzman
Research Associate
-
Isha Gupta
Research Associate
-
Jesse Zalatan, PhD
Advisor
-
John Tabone, PhD
Advisor
-
Todd Smith, PhD
Advisor
-
James Carothers, PhD
Advisor
Strategic Advisors
-
Michael Kauffman, MD PhD
CEO at Nereid Therapeutics
-
Wayne Gombotz, PhD
fmr CTO at Alpine Immune Sciences
-
Lance Stewart, PhD
Interim Executive Director at Institute for Protein Design
-
Jay Rothstein, PhD
CSO at Lifordi Immunotherapeutics
-
Tom McCauley, PhD
CEO at Neptune Bio
-
Troy Lionberger, PhD
CBO at Abbratech
fmr SVP at Berkeley Lights
Our Investors
